[Skin transplantation in the study of chemical carcinogenesis. III. Reduced papilloma-formation after initiation during epidermal hyperplasia induced by skin grafting or by a single application of the cocarcinogen TPA].

P K Worst; H K Boukamp

doi:10.1007/bf00304036

Home/Archive/PubMed

PubMed · 127447

[Skin transplantation in the study of chemical carcinogenesis. III. Reduced papilloma-formation after initiation during epidermal hyperplasia induced by skin grafting or by a single application of the cocarcinogen TPA].

P K Worst·H K Boukamp

View original source ↗Export metadata ↓

Abstract

Skin autografting or a single painting with the cocarcinogen TPA was used to induce epidermal hyperplasia in the back skin of C3H mice. Initiation by intragastric application of the carcinogen DMBA during this state of hyperplasia and subsequent promotion by repeated application of the cocarcinogen TPA led to decreased papilloma-formation, as compared to mice of a control group which had not been pretreated before initiation. Reports by others referring to increased susceptibility of replicating epidermal cells to the effect of initiation thus cannot be confirmed. The reduction of papilloma-formation can most probably be ascribed to effects of local inflammation, either preferentially but unspecifically damaging initiated cells, or facilitating a specific immune response against tumor-associated transplantation antigens of prospective tumor cells.

Explore related subjects

9,10-Dimethyl-1,2-benzanthracene Animals Female Hyperplasia Mice Mice, Inbred C3H Papilloma Skin Skin Transplantation Tetradecanoylphorbol Acetate Time Factors Transplantation, Autologous Journal Article

Keep this discovery

Explore connections, maps & timelines

BibTeX RIS

P K Worst, H K Boukamp. 1975-10-27. [Skin transplantation in the study of chemical carcinogenesis. III. Reduced papilloma-formation after initiation during epidermal hyperplasia induced by skin grafting or by a single application of the cocarcinogen TPA].. https://doi.org/10.1007/bf00304036

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed1979

Differential excision of carcinogenic hydrocarbon-DNA adducts in mouse embryo cell cultures.

Explore the source record for details and available documents.

9,10-Dimethyl-1,2-benzanthracene↗

PubMed1979

Combined reversed-phase and normal-phase high-performance liquid chromatography in the purification and identification of 7,12-dimethylbenz[a]anthracene metabolites.

A total of 37 compounds have been identified as rat liver microsomal metabolites of the potent carcinogen 7,12-dimethylbenz[a]anthracene and its hydroxymethyl derivatives 7-methyl-12-hydroxymethylbenz[a]anthracene, 7-hydroxymethyl-12-methylben[a]anthracene and 7,12-dihydroxymethylbenz[a]anthracene. The metabolites were characterized by: (i) retention times on reversed-phase (with a C18 column) and normal-phase (with a silica gel column) high-performance liquid chromatography (HPLC); (ii) ultraviolet absorption and fluorescence spectra; (iii) mass spectral analysis; (iv) optical activity; and (v) comparison of the physicochemical properties of the metabolites with those of some available synthetic standards. The 37 identified metabolites include four trans-3,4-dihydrodiols, four trans-5,6-dihydrodiols, four trans-8,9-dihydrodiols, four trans-10,11-dihydrodiols, two methyl carboxylic acids, two methyl aldehydes, two hydroxymethyl aldehydes, four 2-phenols, four 3-phenols, four 4-phenols and three hydroxymethyl derivatives. The trans configuration of the dihydrodiols was determined by their inability to form vicinal cisacetonides. Seven dihydrodiol metabolites were found to be optically active. Detailed physicochemical properties, such as ultraviolet absorption spectra, fluorescence spectra measured in methanol and in 0.1 N NaOH, major mass ions from mass spectral analysis and the retention times on two HPLC systems, are presented in support of the structural assignments.

9,10-Dimethyl-1,2-benzanthracene↗

PubMed1979

The initiation of tumours on mouse skin by dihydrodiols derived from 7,12-dimethylbenz(a)anthracene and 3-methylcholanthrene.

The cis-2a,3-diol and the trans-4,5-, trans-7,8-, trans-9,10- and trans-11,12-dihydrodiols of 3-methylcholanthrene and the trans-3,4, trans-5,6-, trans-8,9. and trans-10,11- dihydrodiols of 7,12-dimethylbenz[a]anthrancene have been tested, in comparison with the parent hydrocarbons, for their abilities to initiate skin tumours in female CDI mice. Groups of mice received a single topical application (25 micrograms) of a diol or of a hydrocarbon, and 1 week later repeated topical applications (1 microgram) of 12-0-tetradecanoylphorbol-13-acetate were commenced. The results show that the diol of 3-methylcholanthrene and the 3,4-diol of 7,12-dimethylbenz[a]anthrancene were active as initiating agents but that they were no more active than their parent hydrocarbon. The K-region 5,6-diol of 7,12-dimethylbenz[a]anthrancene, which cannot be converted directly into a vicinal diol-epoxide, was also active as a tumour-initiating agent when applied to mouse skin.

9,10-Dimethyl-1,2-benzanthracene↗